A Comparative Study Between Lysine Clonixinate+Cyclobenzaprine and Caffeine+Carisoprodol+Sodium Diclofenac+Paracetamol

Phase 3 Unknown 160 enrolled Farmoquimica S.A. Pharmagenix Projetos em Medicina Farmacêutica Ltda. · collab

RandomizedParallel-groupDouble-blindTreatment

Summary

Non inferiority, multicentric, double blind study whose the primary objective is to compare the effectiveness of two products in pain reduction. Primary endpoint: reduction in pain average at day 7 compared to day 1(baseline), using Analogue Visual Scale (AVS) for pain evaluation. Secondary endpoint: to evaluate the products safety at the gastrointestinal system.

Timeline

Start: 2012-05
Primary completion: 2012-08
Completion: 2013-01

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Acetaminophen	Small molecule	—	Oral
Subject	Caffeine	Small molecule	—	Oral
Subject	Carisoprodol	Small molecule	—	Oral
Subject	Diclofenac	Other / unclassified	—	Oral
Subject	clonixinate	Unknown	—	Oral
Subject	cyclobenzaprine	Small molecule	—	Oral

Indications

No indication recorded.